Myositis clinical trials at University of California Health

1 research study open to eligible people

Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
open to eligible people ages 18 years and up
The purpose of this study is to evaluate the efficacy and safety of Nipocalimab versus placebo in participants with active idiopathic inflammatory myopathies (IIM).
at UC Irvine UCLA

Last updated: November 8, 2023